epirubicin , a stereoisomer of doxorubicin with suggested lower potential for cardiotoxicity in experimental animal tumor systems , was studied in a disease-oriented phase ii trial in patients with advanced colorectal cancer .
C0014582
epirubicin
C0013089
doxorubicin